Abstract:Introduction Patients with genetic cardiomyopathies (GCM) are at higher risk for adverse outcomes than those with acquired cardiomyopathies. In order to mitigate adverse outcomes through timely implementation of heart failure therapies and in some cases precision medical therapies, the identification of GCM is critical. Clinical genetic testing can identify the etiology of DCM in 40-50% of familial cases, in 10-25% of isolated DCM cases, and in 30-60% of HCM cases. However, which patients should undergo genetic testing remains unclear. Both the Madrid Genotype Score and delayed enhancement patterns on cardiac MRI have been proposed as methods for identifying patients with DCM at risk for a GCM. Aim We sought to determine the incidence of GCM among patients with a cMRI pattern suggestive of GCM based on late gadolinium enhancement (LGE). We further hypothesized that the MADRID score could risk stratify these patients for a GCM. Among these patients, we hypothesize individuals with a low MADRID score (<2) are more likely to have a negative genetic test compared to those with a higher MADRID score. Methods We evaluated 45 individuals with cMRI findings suggestive of GCM with available genetic testing results. The MADRID score was calculated based on chart review for the presence of (a) a skeletal myopathy, (b) a family history of DCM, (c) low voltage on ECG, (d) the absence of hypertension, and (e) absence of left bundle branch block.We then used a two-sample t-test with unequal variances and Kruskal-Wallis test to determine the difference in MADRID score among patients with a positive genetic test [pathogenic variant (PV) or variant of uncertain significance (VUS)] versus those with a negative genetic test. Results Of 45 individuals with LGE patterns of possible GCM, 35 (78%) had genetic test results with either a PV (n=23) or VUS (n=12). Mean MADRID scores were higher among individuals with PV compared to those with VUS (p=0.02) and compared to those with negative genetic testing (p=0.002). There were no individuals with a negative genetic test with a MADRID score above 2. Applying the MADRID score to this cohort led to a relative increase in yield of genetic testing compared to prior validation cohorts. Conclusion A combined approach of cardiac MRI and the MADRID genotype score may help identify patients at risk for GCM better than either approach alone. This combined approach can help increase the yield of clinical genetic testing. Additional studies with larger sample sizes are needed to better understand the value of applying the MADRID score to patients with cMRI patterns concerning for GCM.

Combined Usage Of CMRI And The Madrid Genotype Score To Identify Genetic Cardiomyopathies

Improving the yield of genetic testing in dilated cardiomyopathy using late gadolinium enhancement

A Risk Score to Diagnose Cardiac Involvement and Provide Prognosis Information in Patients at Risk of Cardiac Light-Chain Amyloidosis

Enhancement of the Mayo Clinic Genotype Predictor Score using Cardiac MRI

Deep Learning-Derived 12-Lead Electrocardiogram-Based Genotype Prediction for Hypertrophic Cardiomyopathy: a Pilot Study.

Myocardial Contraction Fraction as a Simple Marker of Disease Severity in Hypertrophic Cardiomyopathy

Association of a Genetic Risk Score with Prevalent and Incident Myocardial Infarction in Subjects Undergoing Coronary Angiography.

Role of advanced CMR features in identifying a positive genotype of hypertrophic cardiomyopathy

Evidence Of Genetic Testing In A Large, Real-world DCM Cohort And Association With Heart Failure Risk

Genetic Analysis and Preimplantation Genetic Diagnosis of Chinese Marfan Syndrome Patients

Cardiac MRI traits linked to cardiomyopathy mutations in phenotype naive carriers

Cardiac magnetic resonance markers of pre-clinical hypertrophic and dilated cardiomyopathy in genetic variant carriers

Refining risk stratification in hypertrophic cardiomyopathy: the role of late gadolinium enhancement and syncope in predicting adverse outcomes

Late gadolinium enhancement on cardiac MRI: A systematic review and meta-analysis of prognosis across cardiomyopathies

Prognostic implications of genotype findings in non-ischemic dilated cardiomyopathy: a network meta-analysis

Is genetic information helpful in predicting recurrent events in young patients after acute coronary syndrome?

Global Circumferential Strain by Cardiac Magnetic Resonance Tissue Tracking Associated With Ventricular Arrhythmias in Hypertrophic Cardiomyopathy Patients

Redefining genotype-phenotype correlation among patients with arrhythmogenic cardiomyopathy: a CMR cohort study

Myocardial Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR)—An Important Risk Marker for Cardiac Disease

Predictors of appropriate ICD discharges and the additive role of late gadolinium enhancement in hypertrophic cardiomyopathy

Cardiac MRI-Enriched Phenomapping Classification and Differential Treatment Outcomes in Patients With Ischemic Cardiomyopathy